Cargando…

The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta-analysis

BACKGROUND: Although programmed cell death ligand 1 (PD-L1) expression and function in hematologic malignancies have aroused extensive attention, its prognostic value for extranodal natural killer/T-cell lymphoma (ENKTL) is still unknown. Therefore, we conducted this meta-analysis to explore the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wen, Zheng, Qiaoling, Luo, Xiaofeng, Zhang, Xinyue, Zheng, Xin, Yang, Yinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493804/
https://www.ncbi.nlm.nih.gov/pubmed/37701117
http://dx.doi.org/10.21037/tcr-22-2569
_version_ 1785104546513551360
author Li, Wen
Zheng, Qiaoling
Luo, Xiaofeng
Zhang, Xinyue
Zheng, Xin
Yang, Yinghong
author_facet Li, Wen
Zheng, Qiaoling
Luo, Xiaofeng
Zhang, Xinyue
Zheng, Xin
Yang, Yinghong
author_sort Li, Wen
collection PubMed
description BACKGROUND: Although programmed cell death ligand 1 (PD-L1) expression and function in hematologic malignancies have aroused extensive attention, its prognostic value for extranodal natural killer/T-cell lymphoma (ENKTL) is still unknown. Therefore, we conducted this meta-analysis to explore the predictive value of neoplastic PD-L1 expression for ENKTL. METHODS: The PubMed, Embase, Web of Science, and CNKI databases were searched to identify eligible observational studies reporting PD-L1 expression and survival outcomes of ENKTL patients. The search was conducted in accordance with the Meta-analyses Of Observative Studies in Epidemiology (MOOSE) guidelines. The pooled hazard ratios (HRs) and 95% confidence intervals (95% CIs) were adopted to analyze survival outcomes, and the odds ratios (ORs) and 95% CIs were adopted for clinicopathological parameters. Review Manager 5.3 and STATA 17.0 were used for statistical analysis. Potential publication bias was evaluated by funnel plot and Egger’s test. RESULTS: A total of 433 patients with ENKTL were included across seven studies. The pooled results showed no significant relationship between neoplastic PD-L1 expression and overall survival (OS) (HR =1.35, 95% CI: 0.49–3.75, P=0.559). We also performed subgroup analyses. However, increased PD-L1 expression was associated with a low international prognostic index (IPI) score of 0–1 (OR =2.46; 95% CI: 1.11–5.45, P=0.03), good performance status (OR =1.97; 95% CI: 1.11–3.51, P=0.02), and a good treatment effect (OR =2.61; 95% CI: 1.01–6.70, P=0.05). CONCLUSIONS: PD-L1-positive expression in patients with ENKTL was correlated with favorable clinical features. Thus, PD-L1-positive expression appears to be a potential predictor of treatment benefits. Additional large-scale, high-quality studies are needed to further explore its predictive value.
format Online
Article
Text
id pubmed-10493804
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-104938042023-09-12 The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta-analysis Li, Wen Zheng, Qiaoling Luo, Xiaofeng Zhang, Xinyue Zheng, Xin Yang, Yinghong Transl Cancer Res Original Article BACKGROUND: Although programmed cell death ligand 1 (PD-L1) expression and function in hematologic malignancies have aroused extensive attention, its prognostic value for extranodal natural killer/T-cell lymphoma (ENKTL) is still unknown. Therefore, we conducted this meta-analysis to explore the predictive value of neoplastic PD-L1 expression for ENKTL. METHODS: The PubMed, Embase, Web of Science, and CNKI databases were searched to identify eligible observational studies reporting PD-L1 expression and survival outcomes of ENKTL patients. The search was conducted in accordance with the Meta-analyses Of Observative Studies in Epidemiology (MOOSE) guidelines. The pooled hazard ratios (HRs) and 95% confidence intervals (95% CIs) were adopted to analyze survival outcomes, and the odds ratios (ORs) and 95% CIs were adopted for clinicopathological parameters. Review Manager 5.3 and STATA 17.0 were used for statistical analysis. Potential publication bias was evaluated by funnel plot and Egger’s test. RESULTS: A total of 433 patients with ENKTL were included across seven studies. The pooled results showed no significant relationship between neoplastic PD-L1 expression and overall survival (OS) (HR =1.35, 95% CI: 0.49–3.75, P=0.559). We also performed subgroup analyses. However, increased PD-L1 expression was associated with a low international prognostic index (IPI) score of 0–1 (OR =2.46; 95% CI: 1.11–5.45, P=0.03), good performance status (OR =1.97; 95% CI: 1.11–3.51, P=0.02), and a good treatment effect (OR =2.61; 95% CI: 1.01–6.70, P=0.05). CONCLUSIONS: PD-L1-positive expression in patients with ENKTL was correlated with favorable clinical features. Thus, PD-L1-positive expression appears to be a potential predictor of treatment benefits. Additional large-scale, high-quality studies are needed to further explore its predictive value. AME Publishing Company 2023-08-28 2023-08-31 /pmc/articles/PMC10493804/ /pubmed/37701117 http://dx.doi.org/10.21037/tcr-22-2569 Text en 2023 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Li, Wen
Zheng, Qiaoling
Luo, Xiaofeng
Zhang, Xinyue
Zheng, Xin
Yang, Yinghong
The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta-analysis
title The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta-analysis
title_full The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta-analysis
title_fullStr The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta-analysis
title_full_unstemmed The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta-analysis
title_short The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta-analysis
title_sort predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/t-cell lymphoma and its correlation with clinicopathological features: a systematic review and meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493804/
https://www.ncbi.nlm.nih.gov/pubmed/37701117
http://dx.doi.org/10.21037/tcr-22-2569
work_keys_str_mv AT liwen thepredictiveimplicationofprogrammedcelldeathligand1expressioninextranodalnaturalkillertcelllymphomaanditscorrelationwithclinicopathologicalfeaturesasystematicreviewandmetaanalysis
AT zhengqiaoling thepredictiveimplicationofprogrammedcelldeathligand1expressioninextranodalnaturalkillertcelllymphomaanditscorrelationwithclinicopathologicalfeaturesasystematicreviewandmetaanalysis
AT luoxiaofeng thepredictiveimplicationofprogrammedcelldeathligand1expressioninextranodalnaturalkillertcelllymphomaanditscorrelationwithclinicopathologicalfeaturesasystematicreviewandmetaanalysis
AT zhangxinyue thepredictiveimplicationofprogrammedcelldeathligand1expressioninextranodalnaturalkillertcelllymphomaanditscorrelationwithclinicopathologicalfeaturesasystematicreviewandmetaanalysis
AT zhengxin thepredictiveimplicationofprogrammedcelldeathligand1expressioninextranodalnaturalkillertcelllymphomaanditscorrelationwithclinicopathologicalfeaturesasystematicreviewandmetaanalysis
AT yangyinghong thepredictiveimplicationofprogrammedcelldeathligand1expressioninextranodalnaturalkillertcelllymphomaanditscorrelationwithclinicopathologicalfeaturesasystematicreviewandmetaanalysis
AT liwen predictiveimplicationofprogrammedcelldeathligand1expressioninextranodalnaturalkillertcelllymphomaanditscorrelationwithclinicopathologicalfeaturesasystematicreviewandmetaanalysis
AT zhengqiaoling predictiveimplicationofprogrammedcelldeathligand1expressioninextranodalnaturalkillertcelllymphomaanditscorrelationwithclinicopathologicalfeaturesasystematicreviewandmetaanalysis
AT luoxiaofeng predictiveimplicationofprogrammedcelldeathligand1expressioninextranodalnaturalkillertcelllymphomaanditscorrelationwithclinicopathologicalfeaturesasystematicreviewandmetaanalysis
AT zhangxinyue predictiveimplicationofprogrammedcelldeathligand1expressioninextranodalnaturalkillertcelllymphomaanditscorrelationwithclinicopathologicalfeaturesasystematicreviewandmetaanalysis
AT zhengxin predictiveimplicationofprogrammedcelldeathligand1expressioninextranodalnaturalkillertcelllymphomaanditscorrelationwithclinicopathologicalfeaturesasystematicreviewandmetaanalysis
AT yangyinghong predictiveimplicationofprogrammedcelldeathligand1expressioninextranodalnaturalkillertcelllymphomaanditscorrelationwithclinicopathologicalfeaturesasystematicreviewandmetaanalysis